Sign up to receive PMC's digital communications.
The Personalized Medicine Coalition, representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems.
Personalized medicine is an evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each patient or use medical interventions to alter molecular mechanisms that impact health. By combining data from diagnostic tests with an individual’s medical history, circumstances and values, health care providers can develop targeted treatment and prevention plans with their patients.
To understand how quickly personalized treatments and diagnostic tools are reaching the United States market, PMC recently conducted its seventh annual analysis of the Food and Drug Administration's activities in personalized medicine. With personalized medicines accounting for more than 25 percent of newly approved drugs for each of the last seven years and topping one-third of new drug approvals for four of the last five, the findings leave no question that the era of personalized medicine is upon us, presenting both opportunities and challenges for patients and health systems.
Use the link provided below to access a PDF version of the report.
» Personalized Medicine at FDA: The Scope & Significance of Progress in 2021